One- and Two-Photon Activated Release of Oxaliplatin from a Pt(IV)-Functionalized Poly(phenylene ethynylene)
We report a water-soluble poly(phenylene ethynylene) (PPE-Pt(IV)) that is functionalized with oxidized oxaliplatin Pt(IV) units and its use for photoactivated chemotherapy. The photoactivation strategy is based on photoinduced electron transfer from the PPE backbone to oxaliplatin Pt(IV) as an e...
Gespeichert in:
Veröffentlicht in: | ACS applied materials & interfaces 2022-04, Vol.14 (14), p.15996-16005 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 16005 |
---|---|
container_issue | 14 |
container_start_page | 15996 |
container_title | ACS applied materials & interfaces |
container_volume | 14 |
creator | Sun, Han Yee, Samantha S Gobeze, Habtom B He, Ru Martinez, Daniel Risinger, April L Schanze, Kirk S |
description | We report a water-soluble poly(phenylene ethynylene) (PPE-Pt(IV)) that is functionalized with oxidized oxaliplatin Pt(IV) units and its use for photoactivated chemotherapy. The photoactivation strategy is based on photoinduced electron transfer from the PPE backbone to oxaliplatin Pt(IV) as an electron acceptor; this process triggers the release of oxaliplatin, which is a clinically used anticancer drug. Mechanistic studies carried out using steady-state and time-resolved fluorescence spectroscopy coupled with picosecond–nanosecond transient absorption support the hypothesis that electron transfer triggers the drug release. Photoactivation is effective, producing oxaliplatin with a good chemical yield in less than 1 h of photolysis (400 nm, 5 mW cm–2). Photorelease of oxaliplatin from PPE-Pt(IV) can also be effected with two-photon excitation by using 100 fs pulsed light at 725 nm. Cytotoxicity studies using SK-OV-3 human ovarian cancer cells demonstrate that without photoactivation PPE-Pt(IV) is not cytotoxic at concentrations up to 10 μM in polymer repeating unit (PRU) concentration. However, following a short period of 460 nm irradiation, oxaliplatin is released from PPE-Pt(IV), resulting in cytotoxicity at concentrations as low as 2.5 μM PRU. |
doi_str_mv | 10.1021/acsami.2c00859 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2646726334</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2646726334</sourcerecordid><originalsourceid>FETCH-LOGICAL-a330t-6040b64f5743aa44af3072df404969a303290511662adf7682807739be0795f33</originalsourceid><addsrcrecordid>eNp1kEtLxDAUhYMojq-tS8lyRuh4m6RpuxwGXyDMIOq23GkTppImtWnV-uutdHTn6h643zmLj5DzEOYhsPAKc49VOWc5QBKle-QoTIUIEhax_b8sxIQce_8KIDmD6JBMeMQlJGlyRMzKqoCiLejThwvWW9c6Sxd5W75jqwr6qIxCr6jTdPWJpqwNtqWlunEVRbpup_cvs-Cms0PB2eH_NXTWzvTTeqtsb5RVVLXbfoyzU3Kg0Xh1trsn5Pnm-ml5Fzysbu-Xi4cAOYc2kCBgI4WOYsERhUDNIWaFFiBSmSIHzlKIwlBKhoWOZcISiGOebhTEaaQ5PyHTcbdu3FunfJtVpc-VMWiV63zGpJAxk5yLAZ2PaN447xuls7opK2z6LITsx3A2Gs52hofCxW6721Sq-MN_lQ7A5QgMxezVdc3gxf-39g1df4RX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2646726334</pqid></control><display><type>article</type><title>One- and Two-Photon Activated Release of Oxaliplatin from a Pt(IV)-Functionalized Poly(phenylene ethynylene)</title><source>MEDLINE</source><source>ACS Publications</source><creator>Sun, Han ; Yee, Samantha S ; Gobeze, Habtom B ; He, Ru ; Martinez, Daniel ; Risinger, April L ; Schanze, Kirk S</creator><creatorcontrib>Sun, Han ; Yee, Samantha S ; Gobeze, Habtom B ; He, Ru ; Martinez, Daniel ; Risinger, April L ; Schanze, Kirk S</creatorcontrib><description>We report a water-soluble poly(phenylene ethynylene) (PPE-Pt(IV)) that is functionalized with oxidized oxaliplatin Pt(IV) units and its use for photoactivated chemotherapy. The photoactivation strategy is based on photoinduced electron transfer from the PPE backbone to oxaliplatin Pt(IV) as an electron acceptor; this process triggers the release of oxaliplatin, which is a clinically used anticancer drug. Mechanistic studies carried out using steady-state and time-resolved fluorescence spectroscopy coupled with picosecond–nanosecond transient absorption support the hypothesis that electron transfer triggers the drug release. Photoactivation is effective, producing oxaliplatin with a good chemical yield in less than 1 h of photolysis (400 nm, 5 mW cm–2). Photorelease of oxaliplatin from PPE-Pt(IV) can also be effected with two-photon excitation by using 100 fs pulsed light at 725 nm. Cytotoxicity studies using SK-OV-3 human ovarian cancer cells demonstrate that without photoactivation PPE-Pt(IV) is not cytotoxic at concentrations up to 10 μM in polymer repeating unit (PRU) concentration. However, following a short period of 460 nm irradiation, oxaliplatin is released from PPE-Pt(IV), resulting in cytotoxicity at concentrations as low as 2.5 μM PRU.</description><identifier>ISSN: 1944-8244</identifier><identifier>ISSN: 1944-8252</identifier><identifier>EISSN: 1944-8252</identifier><identifier>DOI: 10.1021/acsami.2c00859</identifier><identifier>PMID: 35360898</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Biological and Medical Applications of Materials and Interfaces ; Humans ; Oxaliplatin - pharmacology ; Polymers - chemistry ; Spectrometry, Fluorescence</subject><ispartof>ACS applied materials & interfaces, 2022-04, Vol.14 (14), p.15996-16005</ispartof><rights>2022 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a330t-6040b64f5743aa44af3072df404969a303290511662adf7682807739be0795f33</citedby><cites>FETCH-LOGICAL-a330t-6040b64f5743aa44af3072df404969a303290511662adf7682807739be0795f33</cites><orcidid>0000-0001-7953-0183 ; 0000-0001-9087-8121 ; 0000-0003-3342-4080 ; 0000-0001-5519-6846 ; 0000-0002-4363-3268 ; 0000-0002-9058-3283</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acsami.2c00859$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acsami.2c00859$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2763,27075,27923,27924,56737,56787</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35360898$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sun, Han</creatorcontrib><creatorcontrib>Yee, Samantha S</creatorcontrib><creatorcontrib>Gobeze, Habtom B</creatorcontrib><creatorcontrib>He, Ru</creatorcontrib><creatorcontrib>Martinez, Daniel</creatorcontrib><creatorcontrib>Risinger, April L</creatorcontrib><creatorcontrib>Schanze, Kirk S</creatorcontrib><title>One- and Two-Photon Activated Release of Oxaliplatin from a Pt(IV)-Functionalized Poly(phenylene ethynylene)</title><title>ACS applied materials & interfaces</title><addtitle>ACS Appl. Mater. Interfaces</addtitle><description>We report a water-soluble poly(phenylene ethynylene) (PPE-Pt(IV)) that is functionalized with oxidized oxaliplatin Pt(IV) units and its use for photoactivated chemotherapy. The photoactivation strategy is based on photoinduced electron transfer from the PPE backbone to oxaliplatin Pt(IV) as an electron acceptor; this process triggers the release of oxaliplatin, which is a clinically used anticancer drug. Mechanistic studies carried out using steady-state and time-resolved fluorescence spectroscopy coupled with picosecond–nanosecond transient absorption support the hypothesis that electron transfer triggers the drug release. Photoactivation is effective, producing oxaliplatin with a good chemical yield in less than 1 h of photolysis (400 nm, 5 mW cm–2). Photorelease of oxaliplatin from PPE-Pt(IV) can also be effected with two-photon excitation by using 100 fs pulsed light at 725 nm. Cytotoxicity studies using SK-OV-3 human ovarian cancer cells demonstrate that without photoactivation PPE-Pt(IV) is not cytotoxic at concentrations up to 10 μM in polymer repeating unit (PRU) concentration. However, following a short period of 460 nm irradiation, oxaliplatin is released from PPE-Pt(IV), resulting in cytotoxicity at concentrations as low as 2.5 μM PRU.</description><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Biological and Medical Applications of Materials and Interfaces</subject><subject>Humans</subject><subject>Oxaliplatin - pharmacology</subject><subject>Polymers - chemistry</subject><subject>Spectrometry, Fluorescence</subject><issn>1944-8244</issn><issn>1944-8252</issn><issn>1944-8252</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEtLxDAUhYMojq-tS8lyRuh4m6RpuxwGXyDMIOq23GkTppImtWnV-uutdHTn6h643zmLj5DzEOYhsPAKc49VOWc5QBKle-QoTIUIEhax_b8sxIQce_8KIDmD6JBMeMQlJGlyRMzKqoCiLejThwvWW9c6Sxd5W75jqwr6qIxCr6jTdPWJpqwNtqWlunEVRbpup_cvs-Cms0PB2eH_NXTWzvTTeqtsb5RVVLXbfoyzU3Kg0Xh1trsn5Pnm-ml5Fzysbu-Xi4cAOYc2kCBgI4WOYsERhUDNIWaFFiBSmSIHzlKIwlBKhoWOZcISiGOebhTEaaQ5PyHTcbdu3FunfJtVpc-VMWiV63zGpJAxk5yLAZ2PaN447xuls7opK2z6LITsx3A2Gs52hofCxW6721Sq-MN_lQ7A5QgMxezVdc3gxf-39g1df4RX</recordid><startdate>20220413</startdate><enddate>20220413</enddate><creator>Sun, Han</creator><creator>Yee, Samantha S</creator><creator>Gobeze, Habtom B</creator><creator>He, Ru</creator><creator>Martinez, Daniel</creator><creator>Risinger, April L</creator><creator>Schanze, Kirk S</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7953-0183</orcidid><orcidid>https://orcid.org/0000-0001-9087-8121</orcidid><orcidid>https://orcid.org/0000-0003-3342-4080</orcidid><orcidid>https://orcid.org/0000-0001-5519-6846</orcidid><orcidid>https://orcid.org/0000-0002-4363-3268</orcidid><orcidid>https://orcid.org/0000-0002-9058-3283</orcidid></search><sort><creationdate>20220413</creationdate><title>One- and Two-Photon Activated Release of Oxaliplatin from a Pt(IV)-Functionalized Poly(phenylene ethynylene)</title><author>Sun, Han ; Yee, Samantha S ; Gobeze, Habtom B ; He, Ru ; Martinez, Daniel ; Risinger, April L ; Schanze, Kirk S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a330t-6040b64f5743aa44af3072df404969a303290511662adf7682807739be0795f33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Biological and Medical Applications of Materials and Interfaces</topic><topic>Humans</topic><topic>Oxaliplatin - pharmacology</topic><topic>Polymers - chemistry</topic><topic>Spectrometry, Fluorescence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sun, Han</creatorcontrib><creatorcontrib>Yee, Samantha S</creatorcontrib><creatorcontrib>Gobeze, Habtom B</creatorcontrib><creatorcontrib>He, Ru</creatorcontrib><creatorcontrib>Martinez, Daniel</creatorcontrib><creatorcontrib>Risinger, April L</creatorcontrib><creatorcontrib>Schanze, Kirk S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>ACS applied materials & interfaces</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sun, Han</au><au>Yee, Samantha S</au><au>Gobeze, Habtom B</au><au>He, Ru</au><au>Martinez, Daniel</au><au>Risinger, April L</au><au>Schanze, Kirk S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>One- and Two-Photon Activated Release of Oxaliplatin from a Pt(IV)-Functionalized Poly(phenylene ethynylene)</atitle><jtitle>ACS applied materials & interfaces</jtitle><addtitle>ACS Appl. Mater. Interfaces</addtitle><date>2022-04-13</date><risdate>2022</risdate><volume>14</volume><issue>14</issue><spage>15996</spage><epage>16005</epage><pages>15996-16005</pages><issn>1944-8244</issn><issn>1944-8252</issn><eissn>1944-8252</eissn><abstract>We report a water-soluble poly(phenylene ethynylene) (PPE-Pt(IV)) that is functionalized with oxidized oxaliplatin Pt(IV) units and its use for photoactivated chemotherapy. The photoactivation strategy is based on photoinduced electron transfer from the PPE backbone to oxaliplatin Pt(IV) as an electron acceptor; this process triggers the release of oxaliplatin, which is a clinically used anticancer drug. Mechanistic studies carried out using steady-state and time-resolved fluorescence spectroscopy coupled with picosecond–nanosecond transient absorption support the hypothesis that electron transfer triggers the drug release. Photoactivation is effective, producing oxaliplatin with a good chemical yield in less than 1 h of photolysis (400 nm, 5 mW cm–2). Photorelease of oxaliplatin from PPE-Pt(IV) can also be effected with two-photon excitation by using 100 fs pulsed light at 725 nm. Cytotoxicity studies using SK-OV-3 human ovarian cancer cells demonstrate that without photoactivation PPE-Pt(IV) is not cytotoxic at concentrations up to 10 μM in polymer repeating unit (PRU) concentration. However, following a short period of 460 nm irradiation, oxaliplatin is released from PPE-Pt(IV), resulting in cytotoxicity at concentrations as low as 2.5 μM PRU.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>35360898</pmid><doi>10.1021/acsami.2c00859</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-7953-0183</orcidid><orcidid>https://orcid.org/0000-0001-9087-8121</orcidid><orcidid>https://orcid.org/0000-0003-3342-4080</orcidid><orcidid>https://orcid.org/0000-0001-5519-6846</orcidid><orcidid>https://orcid.org/0000-0002-4363-3268</orcidid><orcidid>https://orcid.org/0000-0002-9058-3283</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1944-8244 |
ispartof | ACS applied materials & interfaces, 2022-04, Vol.14 (14), p.15996-16005 |
issn | 1944-8244 1944-8252 1944-8252 |
language | eng |
recordid | cdi_proquest_miscellaneous_2646726334 |
source | MEDLINE; ACS Publications |
subjects | Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Biological and Medical Applications of Materials and Interfaces Humans Oxaliplatin - pharmacology Polymers - chemistry Spectrometry, Fluorescence |
title | One- and Two-Photon Activated Release of Oxaliplatin from a Pt(IV)-Functionalized Poly(phenylene ethynylene) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T05%3A28%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=One-%20and%20Two-Photon%20Activated%20Release%20of%20Oxaliplatin%20from%20a%20Pt(IV)-Functionalized%20Poly(phenylene%20ethynylene)&rft.jtitle=ACS%20applied%20materials%20&%20interfaces&rft.au=Sun,%20Han&rft.date=2022-04-13&rft.volume=14&rft.issue=14&rft.spage=15996&rft.epage=16005&rft.pages=15996-16005&rft.issn=1944-8244&rft.eissn=1944-8252&rft_id=info:doi/10.1021/acsami.2c00859&rft_dat=%3Cproquest_cross%3E2646726334%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2646726334&rft_id=info:pmid/35360898&rfr_iscdi=true |